Literature DB >> 9312039

Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region.

P Stumptner1, P Benaroch.   

Abstract

Association of the invariant chain (Ii) with MHC class II alpha and beta chains is central for their functionality and involves the Ii CLIP(81-104) region. Ii mutants with an antigenic peptide sequence in place of the CLIP region are shown to form alphabetaIi complexes resistant to dissociation by SDS at 25 degrees C. This reflects class II peptide binding site occupancy, since substitution of the major anchor residue within the antigenic peptide sequence of one of these Ii mutants abolishes its capacity to form SDS-stable heterotrimers. Therefore, CLIP location within Ii is compatible with CLIP access to the class II binding groove. However, in wild-type Ii this access does not lead to a tight association, which seems to be affected by the Ii 81-90 region. This region, together with a region C-terminal of CLIP, is shown to contribute to Ii association with HLA-DR1 molecules. Thus, Ii mutants with non-HLA-DR1 binding sequences in place of the CLIP(87-102) region can still associate with HLA-DR1 molecules and inhibit peptide binding.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9312039      PMCID: PMC1170212          DOI: 10.1038/sj.emboj.7590555

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  47 in total

1.  Intracellular transport of class II MHC molecules directed by invariant chain.

Authors:  V Lotteau; L Teyton; A Peleraux; T Nilsson; L Karlsson; S L Schmid; V Quaranta; P A Peterson
Journal:  Nature       Date:  1990-12-13       Impact factor: 49.962

2.  Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways.

Authors:  L Teyton; D O'Sullivan; P W Dickson; V Lotteau; A Sette; P Fink; P A Peterson
Journal:  Nature       Date:  1990-11-01       Impact factor: 49.962

3.  MHC class II-associated invariant chain contains a sorting signal for endosomal compartments.

Authors:  O Bakke; B Dobberstein
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

4.  Truncation analysis of several DR binding epitopes.

Authors:  D O'Sullivan; J Sidney; M F Del Guercio; S M Colón; A Sette
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

5.  On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs.

Authors:  D O'Sullivan; T Arrhenius; J Sidney; M F Del Guercio; M Albertson; M Wall; C Oseroff; S Southwood; S M Colón; F C Gaeta
Journal:  J Immunol       Date:  1991-10-15       Impact factor: 5.422

6.  MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding.

Authors:  R N Germain; L R Hendrix
Journal:  Nature       Date:  1991-09-12       Impact factor: 49.962

7.  High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR.

Authors:  P A Roche; P Cresswell
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

8.  Structural model of HLA-DR1 restricted T cell antigen recognition.

Authors:  J B Rothbard; R I Lechler; K Howland; V Bal; D D Eckels; R Sekaly; E O Long; W R Taylor; J R Lamb
Journal:  Cell       Date:  1988-02-26       Impact factor: 41.582

9.  Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding.

Authors:  T S Jardetzky; J C Gorga; R Busch; J Rothbard; J L Strominger; D C Wiley
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

10.  High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations.

Authors:  J Hammer; C Belunis; D Bolin; J Papadopoulos; R Walsky; J Higelin; W Danho; F Sinigaglia; Z A Nagy
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

View more
  10 in total

Review 1.  HLA-DM and the MHC class II antigen presentation pathway.

Authors:  P E Jensen; D A Weber; W P Thayer; X Chen; C T Dao
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Human immunodeficiency virus-1 Nef expression induces intracellular accumulation of multivesicular bodies and major histocompatibility complex class II complexes: potential role of phosphatidylinositol 3-kinase.

Authors:  Pamela Stumptner-Cuvelette; Mabel Jouve; Julie Helft; Marc Dugast; Anne-Sophie Glouzman; Karin Jooss; Graça Raposo; Philippe Benaroch
Journal:  Mol Biol Cell       Date:  2003-09-17       Impact factor: 4.138

3.  Glycoprotein B from strain 17 of herpes simplex virus type I contains an invariant chain homologous sequence that binds to MHC class II molecules.

Authors:  Elisabeth Sievers; Jürgen Neumann; Martin Raftery; Günther SchOnrich; Anna Maria Eis-Hübinger; Norbert Koch
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

4.  Conformational variants of class II MHC/peptide complexes induced by N- and C-terminal extensions of minimal peptide epitopes.

Authors:  O Rötzschke; K Falk; J Mack; J M Lau; G Jung; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 5.  Antigen processing and immune regulation in the response to tumours.

Authors:  Emma Reeves; Edward James
Journal:  Immunology       Date:  2016-10-12       Impact factor: 7.397

6.  The MHC class II-associated invariant chain interacts with the neonatal Fc gamma receptor and modulates its trafficking to endosomal/lysosomal compartments.

Authors:  Lilin Ye; Xindong Liu; Subrat N Rout; Zili Li; Yongqi Yan; Li Lu; Tirumalai Kamala; Navreet K Nanda; Wenxia Song; Siba K Samal; Xiaoping Zhu
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

Review 7.  Rab GTPases in the differential processing of phagocytosed pathogens versus efferocytosed apoptotic cells.

Authors:  Nima Taefehshokr; Charles Yin; Bryan Heit
Journal:  Histol Histopathol       Date:  2020-09-29       Impact factor: 2.303

8.  Boosting immune response with the invariant chain segments via association with non-peptide binding region of major histocompatibility complex class II molecules.

Authors:  Fangfang Chen; Fantao Meng; Ling Pan; Fazhi Xu; Xuelan Liu; Weiyi Yu
Journal:  BMC Immunol       Date:  2012-09-27       Impact factor: 3.615

9.  MHC structure and function - antigen presentation. Part 2.

Authors:  Anna Carla Goldberg; Luiz Vicente Rizzo
Journal:  Einstein (Sao Paulo)       Date:  2015-03-24

10.  Exogenous Thyropin from p41 Invariant Chain Diminishes Cysteine Protease Activity and Affects IL-12 Secretion during Maturation of Human Dendritic Cells.

Authors:  Tina Zavašnik-Bergant; Martina Bergant Marušič
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.